ArticleFrontiers in oncology2026
Diagnostic performance of multimodal ultrasound-based deep learning models in differentiating benign and malignant thyroid nodules.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multimodal ultrasound (US), including superb microvascular imaging (SMI) and shear-wave elastography (SWE), provides complementary information on tumor angiogenesis and tissue stiffness, which may enhance the diagnostic performance of deep learning (DL) models for thyroid nodules. However, current evidence remains limited and lacks comparative evaluation across different DL architectures. This study aimed to explore the performance of different DL models for differentiating benign and malignant thyroid nodules based on multimodal US images. Methods: This retrospective study involved 735 patients with surgically or pathologically confirmed thyroid nodules. A total of 15,373 multimodal US images, including B-mode (both longitudinal and transverse views), SMI, and SWE, were randomly divided at the image level into training (N = 11,530) and validation (N = 3,843) cohorts at a 3:1 ratio. Four convolutional neural networks, including ResNet50, DenseNet121, VGG16, and GoogLeNet, were trained and validated. The diagnostic performance of these models was compared with junior, intermediate, and senior radiologists. Gradient-weighted Class Activation Mapping (Grad-CAM) was employed to visualize the model's areas of focus. Results: In the validation cohort, the ResNet50 model achieved the highest diagnostic performance [area under the curve (AUC): 0.931], followed by DenseNet121 (AUC = 0.857), VGG16 (AUC = 0.846), and GoogLeNet (AUC = 0.811). Delong's test showed that the AUC of ResNet50 model was higher than that of the other models (all Conclusion: The multimodal US-based DL models achieve satisfactory performance in differentiating benign and malignant thyroid nodules, with the ResNet50 model possessing the highest performance, which may be comparable to intermediate radiologists.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.